Registrations now open !! : Eradicate Cancer 2020 Next frontiers in immunotherapy
By Karen Loudon / September 13, 2019
https://www.eradicatecancer2020.org We are excited to announce that registrations & abstract submissions for Eradicate Cancer 2020 are now open! The field of...
Read More
Australian Scientist wins “America’s Nobels”
By Karen Loudon / September 10, 2019
Congratulations to Cartherics' Scientific Advisor Jacques Miller. He co-shares the 2019 Lasker Award for medical research. Australian scientist, Professor Jacques...
Read More
Trials in Immune-Oncology
By Karen Loudon / September 6, 2019
The expansion of immunotherapies is a key trend to watch in cancer research 28 August, Sophie Laurenson, PhD https://www.clinicallabmanager.com Immunotherapy...
Read More
The Social Costs of Delaying Effective Cancer Treatment Using CAR-T Immunotherapy
By Karen Loudon / September 5, 2019
CAR-T therapy can save lives and boost benefits to society … if it’s delivered promptly, says Cartherics CEO and Executive...
Read More
MEETING ON THE MESA: Cartherics heads to California
By Karen Loudon / September 3, 2019
By Leigh Dayton, 2 September 2019 Cartherics has been invited to present at the prestigious Cell & Gene Meeting on...
Read More
Flow cytometry: The core characterisation technique for developing next-generation cancer immunotherapies
By Karen Loudon / August 28, 2019
CAR-T immunotherapy involves genetically engineering T-cells with chimeric antigen receptors (CARs). FLOW cytometry uses antibodies tagged with fluorescent markers that...
Read More
Monash University Student Open Day
By Karen Loudon / August 27, 2019
A student development evening was held again this year on 26 August 2019 at Monash University Clayton where Professor Graham...
Read More
Can an immune strategy used to treat cancer also wipe out HIV infections?
By Karen Loudon / August 12, 2019
Drugs work stunningly well to control HIV—but not in everyone, and not without side effects. That's why a small cadre...
Read More
Clinical Trials Bite Off Chunk of CAR T Therapy Market
By Karen Loudon / August 6, 2019
https://www.the-scientist.com/news-opinion/clinical-trials-bite-off-chunk-of-car-t-therapy-market-66212 About a quarter of lymphoma patients eligible for the cancer treatments are opting for experimental—and free—options instead. Jul 30,...
Read More
CAR-T Cell Cancer Therapy to Save Lives (Media Release)
By Karen Loudon / August 5, 2019
https://www.premier.vic.gov.au/car-t-cell-cancer-therapy-to-save-lives/ The Victorian and Commonwealth Governments work together to make CAR-T Cell Therapy available to patients CAR-T Cell Therapy is...
Read More
Australian Actor Tom Long cancer-free after medical trial
By Karen Loudon / July 29, 2019
The Age, 28 July 2019 By Melissa Cunningham Former SeaChange actor Tom Long was on the brink of death when...
Read More
Cartherics’ research team just got bigger
By Karen Loudon / July 18, 2019
As of July, the number of scientists sharing the work load in Cartherics’ laboratory hit an even dozen. That’s thanks...
Read More
Patent office reopens major CRISPR battle between Broad Institute and Univ. of California
By Karen Loudon / July 3, 2019
STAT Biotech - By Sharon Begley @sxbegle JUNE 25, 2019 The U.S. patent office has declared an interference between a dozen...
Read More
Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting …….
By Karen Loudon / June 24, 2019
Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting with Cartherics Chairman Bob Moses and CEO Alan Trounson celebrating...
Read More
Australian Biotechnology “REALITIES” : From the Laboratory to the Marketplace
By Karen Loudon / June 7, 2019
Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been...
Read More
